To compare two gadolinium contrast agents in terms of global paired diagnostic preference (primary endpoint) for the assessment of contrast-enhanced MR Angiography of the carotid, renal/abdominal and peripheral arteries
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Enrollment
120
0.1 mmol/kg, single dose
Double dose of 0.2 mmol/kg
Radiology Department Zhongshan Hospital, Fudan University
Shanghai, China
Diagnostic Preference
Comparison of a single dose of MultiHance versus the double dose of Magnevist currently used for MR Angiography of the carotid, renal/abdominal/ and peripheral arteries in terms of global diagnostic perference
Time frame: Immediately post dose
Safety comparison of two diagnostic agents
to compare the safety of the two investigational products in patients undergoing CE-MRA of the carotid, renal/abdominal and peripheral arteries
Time frame: UP to 24 hours post dose of each contrast agent
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.